The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...

Climate-resilient agriculture uses biotechnology, biofertilizers, biopesticides, genome-edited crops, and AI-driven tools to ...

Jarez Holz says 2026 will be a strong year for biotech stocks. The Mizuho analyst explained why in a recent CNBC interview.

The rumblings of a biotech bubble are getting louder as the Nasdaq Biotech Index has declined about 14% from its peak of $275.40 on February 25th. The recent volatility is a phenomenon that has not ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum ...

Vir Biotechnology’s second-quarter earnings report wasn’t short of big news. The company welcomed a trio of clinical-stage T-cell engagers (TCEs) from Sanofi while discarding a quarter of its ...

A centre of excellence for crop biotechnology is set be established to develop and deploy disease-resistant seeds under a new five-year project, according to the Ministry of Agriculture and Animal ...